Literature DB >> 21105747

2D difference gel electrophoresis analysis of different time points during the course of neoplastic transformation of human mammary epithelial cells.

J Tyson DeAngelis1, Yuanyuan Li, Natalie Mitchell, Landon Wilson, Helen Kim, Trygve O Tollefsbol.   

Abstract

Cell culture models of oncogenesis that use cellular reprogramming to generate a neoplastic cell from a normal cell provide one of the few opportunities to study the early stages of breast cancer development. Human mammary epithelial cells (HMECs) were induced to undergo a neoplastic transformation using defined genetic elements to generate transformed HMECs (THMECs). To identify proteins that displayed significantly different levels of abundance at three consecutive time points in oncogenesis over an 80 day period, protein extracts were analyzed by two-dimensional difference gel electrophoresis (2D-DIGE). Nine proteins were found to be significantly different in abundance: keratin 1, keratin 7, heat shock protein 4A-like, t-complex protein 1, stathmin, gelsolin, FK506 binding protein 5, ribosomal protein P0, and maspin. Keratin 7 and maspin displayed a linear down-regulation over 80 days. All of these proteins have been shown to be involved in the maintenance of a metastatic state including cytoskeletal modifications and motility. We conclude that, following neoplastic induction, THMECs display an early and progressive increase in metastatic potential. Further investigations into the function and regulatory mechanisms of these proteins will provide an unparalleled understanding of the initial states through which a breast cancer cell transitions following acquisition of the genetic abnormalities required for oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21105747      PMCID: PMC3390236          DOI: 10.1021/pr100533k

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  48 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer.

Authors:  Elizabeth Alli; Judy Bash-Babula; Jin-Ming Yang; William N Hait
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

3.  Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

Authors:  B Elenbaas; L Spirio; F Koerner; M D Fleming; D B Zimonjic; J L Donaher; N C Popescu; W C Hahn; R A Weinberg
Journal:  Genes Dev       Date:  2001-01-01       Impact factor: 11.361

4.  Enumeration of the simian virus 40 early region elements necessary for human cell transformation.

Authors:  William C Hahn; Scott K Dessain; Mary W Brooks; Jessie E King; Brian Elenbaas; David M Sabatini; James A DeCaprio; Robert A Weinberg
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

5.  Phosphorylation disrupts the central helix in Op18/stathmin and suppresses binding to tubulin.

Authors:  M O Steinmetz; W Jahnke; H Towbin; C García-Echeverría; H Voshol; D Müller; J van Oostrum
Journal:  EMBO Rep       Date:  2001-06       Impact factor: 8.807

6.  Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancers.

Authors:  A D Thor; S M Edgerton; S Liu; D H Moore; D J Kwiatkowski
Journal:  Clin Cancer Res       Date:  2001-08       Impact factor: 12.531

7.  Cell permeant polyphosphoinositide-binding peptides that block cell motility and actin assembly.

Authors:  C C Cunningham; R Vegners; R Bucki; M Funaki; N Korde; J H Hartwig; T P Stossel; P A Janmey
Journal:  J Biol Chem       Date:  2001-08-30       Impact factor: 5.157

Review 8.  The fundamental role of epigenetic events in cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Nat Rev Genet       Date:  2002-06       Impact factor: 53.242

9.  Curcumin inhibits telomerase activity through human telomerase reverse transcritpase in MCF-7 breast cancer cell line.

Authors:  Cheppail Ramachandran; Hugo B Fonseca; Perseus Jhabvala; Enrique A Escalon; Steven J Melnick
Journal:  Cancer Lett       Date:  2002-10-08       Impact factor: 8.679

10.  2D difference gel electrophoresis of prepubertal and pubertal rat mammary gland proteomes.

Authors:  Helen Kim; Mark B Cope; Richie Herring; Gloria Robinson; Landon Wilson; Grier P Page; Stephen Barnes
Journal:  J Proteome Res       Date:  2008-09-04       Impact factor: 4.466

View more
  10 in total

1.  microRNA-101 is a potent inhibitor of autophagy.

Authors:  Lisa B Frankel; Jiayu Wen; Michael Lees; Maria Høyer-Hansen; Thomas Farkas; Anders Krogh; Marja Jäättelä; Anders H Lund
Journal:  EMBO J       Date:  2011-09-13       Impact factor: 11.598

Review 2.  Discovering the Triad between Nav1.5, Breast Cancer, and the Immune System: A Fundamental Review and Future Perspectives.

Authors:  Harishini Rajaratinam; Noor Fatmawati Mokhtar; Nurul Asma-Abdullah; Wan Ezumi Mohd Fuad
Journal:  Biomolecules       Date:  2022-02-15

3.  Inhibition of stathmin1 accelerates the metastatic process.

Authors:  Karin Williams; Ritwik Ghosh; Premkumar Vummidi Giridhar; Guangyu Gu; Thomas Case; Scott M Belcher; Susan Kasper
Journal:  Cancer Res       Date:  2012-08-21       Impact factor: 12.701

4.  Real-time methylomic aberrations during initiation and progression of induced human mammary epithelial cell tumorigenesis.

Authors:  Natalie E Mitchell; MacKenzie L Wilson; Molly S Bray; David K Crossman; Trygve O Tollefsbol
Journal:  Epigenomics       Date:  2013-04       Impact factor: 4.778

5.  In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133high to CD133low phenotype and reduces the CD133-related invasiveness.

Authors:  Federica Brugnoli; Silvia Grassilli; Manuela Piazzi; Maria Palomba; Ervin Nika; Alberto Bavelloni; Silvano Capitani; Valeria Bertagnolo
Journal:  Mol Cancer       Date:  2013-12-13       Impact factor: 27.401

6.  Stathmin is involved in the cooperative effect of Zoledronic acid and gefitinib on bone homing breast cancer cells in vitro.

Authors:  Miki Oda; Keiichi Iwaya; Ryoko Kikuchi; Takayuki Kobayashi; Toshiyuki Yoneda; Kahoko Nishikawa; Osamu Matsubara; Norio Kohno
Journal:  J Bone Oncol       Date:  2012-07-18       Impact factor: 4.072

7.  Combinatorial epigenetic mechanisms and efficacy of early breast cancer inhibition by nutritive botanicals.

Authors:  Yuanyuan Li; Phillip Buckhaults; Xiangqin Cui; Trygve O Tollefsbol
Journal:  Epigenomics       Date:  2016-08-01       Impact factor: 4.778

8.  Maternal soybean genistein on prevention of later-life breast cancer through inherited epigenetic regulations.

Authors:  Min Chen; Shizhao Li; Vinodh Srinivasasainagendra; Manvi Sharma; Zhenhai Li; Hemant Tiwari; Trygve O Tollefsbol; Yuanyuan Li
Journal:  Carcinogenesis       Date:  2022-04-25       Impact factor: 4.741

9.  Established breast cancer stem cell markers do not correlate with in vivo tumorigenicity of tumor-initiating cells.

Authors:  Christian Lehmann; Gabriele Jobs; Markus Thomas; Helmut Burtscher; Manfred Kubbies
Journal:  Int J Oncol       Date:  2012-10-05       Impact factor: 5.650

10.  Epigenetic regulation of multiple tumor-related genes leads to suppression of breast tumorigenesis by dietary genistein.

Authors:  Yuanyuan Li; Huaping Chen; Tabitha M Hardy; Trygve O Tollefsbol
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.